Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1643-1649

  Jackson, A M ^a   Kuperman, M B ^a   Montgomery, R A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cell; IgG subclass; kidney transplantation; non HLA antibody; rejection

Indexed keywords

BORTEZOMIB; CD20 ANTIBODY; COMPLEMENT COMPONENT C4D; DACLIZUMAB; ECULIZUMAB; HLA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; RITUXIMAB; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; ENDOTHELIUM; HUMAN; HUMAN CELL; HYPERACUTE GRAFT REJECTION; HYPOTENSION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETRANSPLANTATION; RETROSPECTIVE STUDY; SPLEEN CELL; SPLENECTOMY; VASCULAR ACCESS;

CELLS, CULTURED; COMPLEMENT ACTIVATION; ENDOTHELIUM; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84861808921     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03955.x     Document Type: Article

References (20)

1. Jordan SC, Yap HK, Sakai RS, Alfonso P, Fitchman M,. Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. Transplantation 1988; 46: 585-587.
2. Harmer AW, Haskard D, Koffman CG, Welsh KI,. Novel antibodies associated with unexplained loss of renal allografts. Transplant Int 1990; 3: 66-69.
3. Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E,. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997; 5: 321-327.
4. Cerilli J, Bay W, Brasile L,. The significance of the monocyte crossmatch in recipients of living-related HLA identical kidney grafts. Hum Immunol 1983; 7: 45-50.
5. Kalil J, Guilherme L, Neumann J, et al,. Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc 1989; 21: 711-713.
6. Zachary AA, Lucas DP, Detrick B, Leffell MS,. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 2009; 70: 496-501.
7. Jackson AM, Lucas DP, Melancon JK, Desai NM,. Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation 2011; 92: 54-60.
8. Nieto A, Cabrera CM, Catalina P, et al,. Effect of mitomycin-C on human foreskin fibroblasts used as feeders in human embryonic stem cells: Immunocytochemistry MIB1 score and DNA ploidy and apoptosis evaluated by flow cytometry. Cell Biol Int 2007; 31: 269-278.
9. Solez K, Colvin RB, Racusen LC, et al,. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760.
10. Kaplan B, Jie T, Diana R, et al,. Histopathology and immunophenotype of the spleen during acute antibody-mediated rejection. Am J Transplant 2010; 10: 1316-1320.
11. Jourdan M, Caraux A, De Vos J, et al,. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009; 114: 5173-5181.
12. Ronda C, Borba SC, Ferreira SC, et al,. Non-human leukocyte antigen antibodies reactive with endothelial cells could be involved in early loss of renal allografts. Transplant Proc 2011; 43: 1345-1348.
13. Locke JE, Magro CM, Singer AL, et al,. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant 2009; 9: 231-235.
14. Dragun D, Muller DN, Brasen JH, et al,. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569.
15. Jurcevic S, Ainsworth ME, Pomerance A, et al,. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886-892.
16. Joosten SA, Sijpkens YW, van Ham V, et al,. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005; 5: 383-393.
17. Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P,. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917-924.
18. Mizutani K, Terasaki P, Bignon JD, et al,. Association of kidney transplant failure and antibodies against MICA. Hum Immunol 2006; 67: 683-691.
19. Li L, Sigdel T, Vitalone M, Lee SH, Sarwal M,. Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation. J Proteome Res 2010; 9: 6715-6721.
20. Dinavahi R, George A, Tretin A, et al,. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol 2011; 22: 1168-1178.